Equity in Action | Addressing Biomarker Disparities in Lung Cancer
https://vimeo.com/940980657 How can biomarker disparities be reduced in lung cancer patients? Experts Dr. Joshua Sabari from NYU Langone and Dr. Eugene Manley from SCHEQ Foundation discuss approaches that are being…
When Should Lung Cancer Patients Receive Biomarker Testing?
https://vimeo.com/940980708 Biomarker testing is vital for non-small cell lung cancer (NSCLC) patients, but when should it happen? Expert Dr. Joshua Sabari from NYU Langone discusses cancer cell mutations and ideal…
Navigating Lung Cancer Biomarker Testing | Challenges and Solutions for Timely Access
https://vimeo.com/940980739 To achieve accurate biomarker data for lung cancer patients, what are challenges and solutions? Expert Dr. Joshua Sabari from NYU Langone discusses challenges that can arise during the biomarker…
Understanding Non-Small Cell Lung Cancer: Types, Biomarkers, and Treatment Insights
https://vimeo.com/940980774 How can non-small cell lung cancer (NSCLC) patients be empowered when newly diagnosed? Expert Dr. Joshua Sabari from NYU Langone discusses what he shares about NSCLC incidence rates, histology,…
How Can Bispecific Antibody Therapy Care Partners Be Proactive?
https://vimeo.com/940909348 What are some ways for myeloma bispecific antibody therapy care partners to be proactive? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute shares lifestyle modifications, reasons to speak up…
Bispecific Antibody Therapy Support | Care Team Members and Resources
https://vimeo.com/940909300 What should myeloma patients know about bispecific antibody therapy support? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses care team members and support resources for bispecific antibody therapy…
What Is the Role of a Care Partner in Bispecific Antibody Therapy?
https://vimeo.com/940909265 How can a myeloma care partner support a bispecific antibody therapy patient? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute explains ways that care partners can offer logistical and…
Bispecific Antibody Therapy | What Is the Treatment Duration and Response?
https://vimeo.com/940909235 What can myeloma bispecific antibody therapy patients expect for treatment duration and response? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses treatment factors that may impact response, common…
Bispecific Antibody Therapy | Managing Side Effects
https://vimeo.com/940909187?fl=pl&fe=sh What should myeloma bispecific antibody therapy patients know about managing side effects? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses common short-term and long-term side effects, members of…
How Is Bispecific Antibody Therapy Administered?
https://vimeo.com/940909156 How is myeloma bispecific antibody therapy given to patients? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute explains how the treatment is administered in the body, hospital types to…
Bispecific Antibodies for Myeloma | Patient Eligibility Requirements
https://vimeo.com/940909113 What are the myeloma patient eligibility requirements for bispecific antibodies? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses patient types that work well with bispecific antibody therapy, patient…
How Has Bispecific Antibody Therapy Impacted Myeloma Care?
